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HIV-seronegative persons are less likely to become infected 
with Staphylococcus aureus and associated S. aureus 
septicaemia than their HIV-seropositive counterparts.1,2 Studies 
have demonstrated an increased risk of MRSA infection among HIV-
seropositive persons of up to 18 times.3-5 MRSA infection therefore 
presents a public health concern. MRSA infection has also been 
found to be associated with sexually transmitted infections (STIs) 
and genital ulcer disease (GUD) in HIV-seropositive persons.6 GUD 
with associated MRSA infection has only been documented once.6 
The case we present in this report is of chronic genital ulceration 
complicated by MRSA urethritis and bacteraemia. This case of 
chronic GUD with subsequent MRSA infection in an HIV-seropositive 
host also highlights the importance of ruling out concurrent MRSA 
infection in chronic GUD in HIV-seropositive persons.
Case presentation
A 44-year-old HIV-seropositive man with World Health 
Organization (WHO) stage IV disease, who had been on highly 
active anti-retroviral therapy (HAART) of tenofovir, lamivudine 
and efavirenz, and co-trimoxazole prophylaxis since March 2008, 
presented with an 8-month history of genital ulceration and a 
4-month history of urethral pus discharge. He initially noticed 
a small papule on the glans of his penis which increased in size 
and ulcerated. He subsequently developed a yellow non-odorous 
urethral discharge. On review of symptoms, he denied associated 
fevers and chills, or trauma to the site. He had no significant 
previous medical history and denied cigarette smoking, alcohol 
consumption and intravenous drug usage. He was heterosexual, 
denied unsafe sexual practices, and had no history of previous STIs, 
antibiotic use, and recurrent STIs or GUD.
Physical examination revealed a body temperature of 36.1oC, 
pulse rate 86 beats per minute, blood pressure 120/70 mmHg, 
and respiratory rate 12 breaths per minute. Genital examination 
revealed an ulcer involving the glans of the penis with a yellow 
urethral discharge. Precordial, ophthalmic, gastrointestinal and 
respiratory examinations were unremarkable. Neurologically, 
there were no cranial nerve deficits, reflexes were symmetrical and 
normal, and distal sensation was intact.
Laboratory data revealed a white blood cell (WBC) count of 
5 000/mm3 and an elevated erythrocyte sedimentation rate (ESR) 
of 80 mm/hr. His urine revealed 500 leukocytes/ul, trace protein, 
66 white blood cells/high-power field (hpf ) and 1 cast/hpf. The 
rest of the routine laboratory tests including renal function tests, 
liver function tests, random blood sugar (RBS), Treponemal 
pallidum haemagglutination assay (TPHA), serum cryptococcal 
antigen (CRAG) titres, hepatitis B surface antigen (HBsAg) and 
brucella agglutination assay were unremarkable. CD4+ cell counts 
were 944 cells/mm3 (30%), and plasma HIV RNA levels were 
undetectable. Herpes simplex virus-2 (HSV-2) serology could not 
be done because of the high costs involved.
A penile wedge biopsy taken for histopathological examination showed 
features suggestive of a chronic penile ulcer. The urethral pus swabs 
and blood cultures grew MRSA sensitive to gentamicin, ciprofloxacin 
and vancomycin but resistant to oxacillin, tetracycline, penicillin and 
erythromycin. Urine cultures depicted no growth. A clinical diagnosis 
of chronic ulcerative genital herpes was made, following consultation 
with an STD specialist. The patient was then admitted and commenced 
on a course of oral acyclovir 400 mg twice daily for 6 months and 
intravenous vancomycin for 2 weeks for chronic ulcerative genital 
herpes and MRSA urethritis and bacteraemia respectively. Intravenous 
ceftriaxone was also administered to treat the urinary tract infection 
(UTI). Continual adherence to co-trimoxazole, acyclovir and HAART was 
continually emphasised.
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The course of treatment was successful; examination at 1 month 
and 2 months follow-up revealed no urethral discharge and 
completely healed penile ulcerations.
DisCussion
HIV-infected persons have a higher risk of MRSA infection than the 
general population. 3-9 The reason why our patient was predisposed 
to MRSA infection could have been a result of the chronic genital 
ulceration.
Prior studies have implicated lack of co-trimoxazole prophylaxis, 
intravenous drug usage, low CD4 T-cell count, high HIV viral load 
and hospitalisation as risk factors for MRSA colonisation in HIV-
seropositive patients.10-12 These factors, however, were not noted 
in our patient. Ramsetty and colleagues demonstrated that HIV-
seropositive patients with CD4 T-cell counts <200 cells/mm3 
were at significant risk of MRSA infections.13 Our patient was the 
exception to this finding, as his CD4 T-cell count was 944 cells/
mm3.
A ramification of this case is the importance of considering 
concurrent MRSA infection in HIV-seropositive patients with 
chronic GUD. Other factors that make this case unique are the 
development of MRSA urethritis and bacteraemia despite the 
patient’s high CD4 T-cell counts and good virological control.
ConClusion
Our patient developed MRSA infection following chronic GUD that was 
not effectively managed. Clinicians need to maintain vigilance in the 
management of chronic GUD in HIV-seropositive persons, as MRSA co-
infection may become an increasing complication in the future.
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Fig. 1. Ulceration and yellow penile urethral discharge. Fig. 2. Ulceration involving entire glans.
